| Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial (NCT04825275) | Milton S. Hershey Medical Center | 2022-05-13 |
| Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas (NCT04869449) | Milton S. Hershey Medical Center | 2022-05-11 |
| [18F]FPIA PET-CT in Glioblastoma Multiforme (GBM) (NCT05801159) | Imperial College London | 2022-04-19 |
| The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors (NCT05116137) | Nova Scotia Health Authority | 2022-03-01 |
| Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma (NCT05076513) | Nader Sanai | 2021-10-29 |
| Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery (NCT04968366) | Beijing Tiantan Hospital | 2021-07-30 |
| Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma (NCT04842513) | University Hospital Tuebingen | 2021-05-03 |
| Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) (NCT04222309) | Northwell Health | 2020-01-06 |
| Trial of C134 in Patients With Recurrent GBM (NCT03657576) | University of Alabama at Birmingham | 2019-09-23 |
| The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. (NCT03861299) | Jasper Gerritsen | 2019-04-01 |
| Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma (NCT03665545) | University Hospital, Geneva | 2018-10-25 |
| Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma (NCT03633552) | Mashhad University of Medical Sciences | 2018-03-03 |
| Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme (NCT03170141) | Shenzhen Geno-Immune Medical Institute | 2017-05-31 |
| Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme (NCT03047473) | Clinique Neuro-Outaouais | 2017-05-19 |
| Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients (NCT02649582) | University Hospital, Antwerp | 2015-12-01 |
| Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study (NCT02474966) | University of Roma La Sapienza | 2014-11-01 |
| MRSI to Predict Response to RT/TMZ ± Belinostat in GBM (NCT02137759) | Emory University | 2014-05-07 |
| Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study (NCT02302235) | Mid-Atlantic Epilepsy and Sleep Center, LLC | 2014-02-01 |
| Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme (NCT00003456) | Burzynski Research Institute | 1995-03-14 |